Vimian Group
35.9 SEK +3.61%3 investors are following this company
Vimian Group is a group active in animal health. Through its subsidiaries, the company delivers medicines and technical solutions to veterinarians, laboratories, and pet owners. The products include, for example, drugs with associated clinical research and digital platforms for veterinary clinics. The company operates worldwide and is headquartered in Stockholm.
Revenue
3.69B
EBIT %
12.44 %
P/E
161.22
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
VIMIAN
Daily low / high price
33.7 / 35.9
SEK
Market cap
18.75B SEK
Turnover
30.21M SEK
Volume
851K
Latest videos
Financial calendar
General meeting
2024-05-22
Interim report
2024-08-15
Interim report
2024-10-24
Annual report
2025-02-13
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Fidelio Vet Holding | 55.3 % | 56.8 % |
Handelsbanken Funds | 4.9 % | 5.0 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Vimian Group, Audiocast with teleconference, Q1, 2024
Vimian’s Interim Report for the first quarter of 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools